Collaborative Innovation Center for Cancer Personalized Medicine, NJMU
南京医科大学 肿瘤个体化医学协同创新中心
China
1 December 2019 - 30 November 2020
Principal institution: Nanjing Medical University (NJMU)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Collaborative Innovation Center for Cancer Personalized Medicine, NJMU published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
8 | 0.35 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 8 | 0.35 |
Top articles by Altmetric score in current window
Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα–mediated lipid metabolism
Journal of Clinical Investigation
2020-05-01
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways
Cancer Cell
2020-06-11
Programmable base editing of mutated promoter inhibits brain tumour growth
Nature Cell Biology
2020-02-17
Remote modulation of lncRNA GCLET by risk variant at 16p13 underlying genetic susceptibility to gastric cancer
Science Advances
2020-05-01

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.